MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s41182-025-00802-9

Медицинская библиотека · Tropical medicine and health · 2025

Screening for Leishmania spp. infection in patients treated with biologic agents for immune-mediated inflammatory diseases: results of an Italian multicentric prospective study.

Balducelli Emma, Torres Ana, Morselli Sara, Angheben Andrea, Piubelli Chiara, Perandin Francesca, Scarso Salvatore, Scambi Cinzia, Bartoloni Alessandro, Zammarchi Lorenzo, Barbiero Anna, Lagi Filippo, Spinicci Michele, Nacci Francesca, Ortalli Margherita, Baiocchi Simone, Bernardo Lorena, Moreno Javier, Carrillo Eugenia, Varani Stefania

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Escalation in the use of biologic agents including tumor necrosis factor (TNF)-α inhibitors to treat immune-mediated inflammatory diseases (IMID) is linked to higher susceptibility of severe infections caused by intracellular pathogens, including Leishmania.

METHODS

This multicentric prospective study assessed the presence of Leishmania spp. infection among patients with IMID under treatment with biologic agents in two Italian clinical centers. We utilized a combination of diagnostic tests: real-time PCR for the detection of parasitic kinetoplast DNA in peripheral blood, Western blot for the identification of serum IgG antibodies, and a Whole blood assay to assess cytokine and chemokine responses following stimulation with parasitic antigen.

RESULTS

A total of 126 patients residing in Italy were enrolled. Patients testing positive in at least one assay were classified as Leishmania-positive. Of the 125 asymptomatic individuals, 25 (20%) tested positive for Leishmania infection, revealing a significant rate of subclinical infection. The most frequent marker of infection was positive serology (15/126, 12%) followed by a detectable cell-mediated immune response (9/125, 7%). Parasitic DNA was detected in 3 patients (2%).

CONCLUSIONS

This study showed a high prevalence of asymptomatic Leishmania infection in Italian patients with IMID under treatment with biologic agents, with a north-to-south gradient. Given the risk of disease reactivation, these patients may benefit from close monitoring. Further research is warranted to clarify the clinical implications of these findings.

Для цитирования: Balducelli Emma, Torres Ana, Morselli Sara, Angheben Andrea, Piubelli Chiara, Perandin Francesca, Scarso Salvatore, Scambi Cinzia, Bartoloni Alessandro, Zammarchi Lorenzo, Barbiero Anna, Lagi Filippo, Spinicci Michele, Nacci Francesca, Ortalli Margherita, Baiocchi Simone, Bernardo Lorena, Moreno Javier, Carrillo Eugenia, Varani Stefania. Screening for Leishmania spp. infection in patients treated with biologic agents for immune-mediated inflammatory diseases: results of an Italian multicentric prospective study.. Tropical medicine and health. 2025. DOI: 10.1186/s41182-025-00802-9.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.